MIRA Pharmaceuticals gains approval for a Phase 1 trial of Ketamir-2 in Israel, aiming to complete by Q4 2025 before moving ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the approval and ...

Adults with neuropathic pain use cannabis products more frequently than those without neuropathic pain. | Cannabis Sciences ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering ...

SciatiSoothe is a natural nerve health support supplement made with plant herbs and natural minerals. The formula is ...

The following is a summary of “A Review of Nonsurgical Neurolytic Procedures for Neuropathic Pain,” published in the February ...

For executives of Lexicon Pharmaceuticals Inc., the missed primary endpoint in the phase IIb Progress study testing pilavapadin, its non-opioid candidate, in adults with moderate to severe diabetic ...

Chronic chemotherapy-induced peripheral neuropathy is a substantial burden among people with cancer treated with chemotherapy ...

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

The cancer can cause 'referred pain' - where you feel discomfort in one area even though the source of the pain is elsewhere ...

Eagles center Cam Jurgens underwent a back procedure Tuesday in Los Angeles to alleviate nerve pain, sources told ESPN's Adam ...

A 45-year-old man diagnosed with trigeminal neuralgia, a condition causing severe facial nerve pain, received successful treatment at a Del.